• Revolutionizing Live-Cell Golgi Imaging for Translational Re

  2026-06-16

  This thought-leadership article explores how Golgi-Tracker Green, a BODIPY FL-labeled C5-ceramide probe from APExBIO, is transforming live-cell Golgi apparatus imaging. By integrating mechanistic insights, comparative benchmarking, and translational relevance, we chart a strategic path for researchers seeking high-fidelity data in sphingolipid metabolism, lipid transport, and disease modeling—especially in cancer biology. The discussion synthesizes evidence from recent tumor-targeted dye studies and outlines best practices for leveraging photostable, highly specific probes. Protocol guidance and a visionary outlook demonstrate how this approach elevates the rigor and impact of translational workflows.

• Telmisartan as an Angiotensin II Receptor Antagonist in Card

  2026-06-15

  Telmisartan from APExBIO provides a robust, reproducible system to interrogate angiotensin II signaling and hypertrophy in cardiovascular disease research. This article spotlights practical setup, protocol refinements, and expert troubleshooting for leveraging Telmisartan in preclinical cardiac models.

• Stiripentol: LDH Inhibitor for Advanced Metabolic Research

  2026-06-15

  Stiripentol enables precise modulation of lactate metabolism and epigenetic signaling, offering a robust tool for dissecting the astrocyte-neuron lactate shuttle and tumor immunometabolism. Its unique LDH inhibition profile and reliable solubility empower advanced protocols in epilepsy and oncology research.

• Thapsigargin: Benchmark SERCA Pump Inhibitor for Calcium Res

  2026-06-14

  Thapsigargin is a potent SERCA pump inhibitor that disrupts intracellular calcium homeostasis with nanomolar efficacy. It is a gold-standard experimental tool for studying calcium signaling, ER stress, and apoptosis. APExBIO's Thapsigargin (B6614) offers high reproducibility for research applications.

• Annexin V-FITC/7-AAD Apoptosis Kit: Technical Workflow Guide

  2026-06-13

  The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid, sensitive method for distinguishing apoptotic and necrotic cells in cell viability and cytotoxicity assays. It is best suited for workflows using flow cytometry or fluorescence microscopy and is not recommended for mechanistic studies beyond phosphatidylserine exposure and membrane integrity. Researchers should be aware of its boundaries and follow recommended protocols for optimal results.

• Heptamethine Cyanine Dye Targets Progesterone Receptor in HR

  2026-06-12

  This study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye, which selectively suppresses progesterone receptor activity and induces Golgi fragmentation in hormone receptor-positive breast cancer. The findings suggest a novel, imaging-enabled therapeutic strategy that bypasses traditional endocrine resistance mechanisms.

• Structure-Based Inhibitor Screening of SARS-CoV-2 NSP15

  2026-06-12

  The referenced study introduces a structure-based virtual screening approach that identifies thymopentin and oleuropein as potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. These findings provide a framework for rational drug repurposing and highlight NSP15 as a viable antiviral target for COVID-19 intervention.

• Anlotinib Hydrochloride: Transforming Angiogenesis in Transl

  2026-06-11

  Explore the mechanistic and strategic value of Anlotinib hydrochloride—a multi-target tyrosine kinase inhibitor—in advancing translational cancer research. This article synthesizes state-of-the-art data on pathway inhibition, experimental best practices, and evolving clinical evidence, while offering actionable guidance for researchers aiming to bridge discovery with impact.

• ISRIB (trans-isomer): Protocols and Pitfalls in PERK Inhibit

  2026-06-11

  ISRIB (trans-isomer) empowers researchers to dissect the integrated stress response with unmatched selectivity, enabling robust workflows in neurodegenerative models and ER stress assays. This article delivers actionable protocol enhancements, troubleshooting wisdom, and practical guidance drawn from the latest breakthrough study on memory and forgetting in epilepsy.

• Dicoumarol Identified as an IRE1α Inhibitor for ER Stress Li

  2026-06-10

  This study introduces a novel screening pipeline that integrates molecular docking and reporter assays to identify dicoumarol as a selective IRE1α inhibitor, offering protection against ER stress-induced liver injury in mice. Its findings highlight new avenues for targeting the unfolded protein response and suggest refined methodologies for ER stress research.

• Transdermal PTEN mRNA Delivery via HA-LNPs for Melanoma Ther

  2026-06-10

  A recent study introduces hyaluronated lipid nanoparticles (HA-LNPs) as a PEG-free platform for transdermal delivery of PTEN mRNA, targeting CD44-expressing melanoma cells. The approach demonstrates effective tumor suppression, immune activation, and low toxicity in preclinical models, highlighting its potential for mRNA-based localized cancer immunotherapy.

• Redefining Reporter mRNA: Mechanisms, Metrics, and Translati

  2026-06-09

  This article dissects the mechanistic advances behind EZ Cap™ EGFP mRNA (5-moUTP), offering translational researchers nuanced guidance for maximizing experimental rigor and clinical relevance. It integrates recent evidence on delivery system sophistication, immune modulation, and translational efficiency, while positioning APExBIO's solution at the forefront of next-generation reporter mRNA technology.

• Estradiol Benzoate: Advanced Workflows in Estrogen Receptor

  2026-06-09

  Estradiol Benzoate streamlines estrogen receptor alpha (ERα) signaling research with unmatched solubility, purity, and reproducibility. Explore robust protocols, troubleshooting strategies, and comparative insights that empower next-generation hormone receptor studies.

• Immune Modulation by Epigenetic Regulators in Melanoma Thera

  2026-06-08

  Anichini et al. provide a comprehensive analysis of immune-related transcriptional changes induced by various epigenetic inhibitors in melanoma, highlighting guadecitabine’s superior capacity to activate innate immunity pathways and enhance immunotherapy response signatures. Their findings support the strategic pairing of DNA methyltransferase inhibition with immune checkpoint blockade in translational oncology.

• Redox-Responsive Peptide Coacervates Advance mRNA Delivery

  2026-06-08

  This study introduces HBpep-SS4, a minimalist, redox-responsive peptide coacervate system that enables efficient, stimulus-triggered cytosolic release of mRNA. By integrating phase separation and glutathione-responsiveness, the platform achieves high encapsulation and delivery efficiency, supporting advanced gene editing and expression assays while addressing limitations of conventional lipid-based carriers.

483 records 7/33 page Previous Next First page 上5页 678910 下5页 Last page